BackBellus Health Overview

Bellus Health Net Income

Bellus Health's net income is $-110M, below the Healthcare sector average of $16B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

-$42.70M
72.82% YoY

As of Sep 2023

Annual Net Income (TTM)

-$108.19M
49.03% YoY

Trailing 12 months ending Sep 2023

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Bellus Health (BLU) FAQ

Bellus Health (BLU) currently reports a net income of $-110M as of September 2023. That compares with $-73M in the prior-year period — down 49.0% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Bellus Health's net income history and peer comparisons.

Bellus Health's net income decreased from $-73M to $-110M — a 49.0% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bellus Health's net income of $-110M is lower than the Healthcare sector average of $16B. That is roughly 100.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Bellus Health reported $-110M in net income as of September 2023. That compares with $-73M in the prior-year period — down 49.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-110M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Bellus Health, and consider following BLU for alerts when major investors trade the stock.